Athira Pharma, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol: ATHA on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 18706 North Creek Parkway, Suite 104, Bothell, WA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+648K	94.6%	$2.41	+$1.56M
Sells	5	-36.8K	5.4%	$2.03	-$74.5K
Net	-3	+611K	89.3%		+$1.49M

Athira Pharma, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Perceptive Advisors Llc	Director, 10%+ Owner	$12.9M	+$1.46M	+12.8%	Dec 27, 2023
Mark James Litton	President and CEO, Director	$285K	-$30.9K	-9.77%	Oct 3, 2024
Hans Moebius	Chief Medical Officer	$266K			Jan 4, 2024
Kelly A. Romano	Director	$195K	+$100K	+105%	Jun 21, 2024
Kevin Church	Chief Scientific Officer	$115K	-$8.45K	-6.86%	Oct 1, 2024
Mark Worthington	General Counsel and CCO	$91.7K	-$15.5K	-14.4%	Oct 1, 2024
Javier San	Chief Medical Officer	$79.2K			Oct 1, 2024
Robert Renninger	VP of Finance	$64.3K			Oct 1, 2024
Andrew Gengos	CFO and Chief Business Officer	$55.2K	-$4.24K	-7.13%	Sep 3, 2024
Rachel Lenington	COO and CDO	$11.8K	-$15.5K	-56.7%	Sep 3, 2024
Tadataka Yamada	Director				May 28, 2021
Grant Pickering	Director				May 24, 2024
Joseph Edelman	Director				May 24, 2024
Glenna Mileson	Chief Financial Officer				Jan 19, 2023
Michael A. Panzara	Director				May 24, 2024
Barbara Kosacz	Director				May 24, 2024
John M. Fluke Jr	Director				May 24, 2024
James A. Johnson	Director				May 24, 2024

Recent Insider Transactions by Companies or Individuals for Athira Pharma, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.